Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions


Multinational Pharmaceutical Companies Perform Well In Latin America In Q411

March 2012 | Industry Trend Analysis

BMI View: Foreign drug companies will increasingly capitalise on Latin America's pharmaceutical market growth by increasing their direct presence in the market and introducing innovative products. However, multinationals have also faced local generic drug competition, drug pricing pressure, foreign exchange risks and a lack of knowledge about local purchase patterns and government policies. We expect multinationals to expand in the region via acquisitions and closer collaborations with local companies and

To read the full article, please choose one of the following options:

Subcribers please log in